Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 43,316 | reported | 19 Mar 2026 | tx 25+532,071−111,030 |
| Global Blood Therapeutics, Inc. | 0 | reported | 05 Oct 2022 | tx 120+575,057−708,197 |
| HYPERION THERAPEUTICS INC | 0 | reported | 07 May 2015 | tx 25+270,027−413,521 |
| RENOVIS INC | 0 | reported | 02 May 2008 | tx 8+36,250−110,744 |
| ZS Pharma, Inc. | 0 | reported | 17 Dec 2015 | tx 2−85,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | GRANT_AWARD | ACHIEVE LIFE SCIENCES, INC. | 47,250 | 0.00 USD | deriv |
| 19 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 2,186 | 67.00 USD | |
| 17 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 2,111 | 69.42 USD | |
| 18 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 2,133 | 68.71 USD | |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 13,042 | — | |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8,020 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 5,022 | 0.00 USD | deriv |
| 05 Mar 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 19,306 | 0.00 USD | deriv |
| 05 Mar 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 30,724 | 0.00 USD | deriv |
| 16 Jun 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 27,881 | — | |
| 17 Jun 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 13,608 | 40.42 USD | |
| 16 Jun 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 27,881 | 0.00 USD | deriv |
| 18 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 1,284 | 46.29 USD | |
| 19 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 1,254 | 47.40 USD | |
| 20 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 1,186 | 50.11 USD | |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8,019 | — | |
| 17 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8,019 | 0.00 USD | deriv |
| 05 Mar 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 30,628 | 0.00 USD | deriv |
| 05 Mar 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 20,089 | 0.00 USD | deriv |
| 17 Jun 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 27,881 | — | |
| 18 Jun 2024 | SALE | Tarsus Pharmaceuticals, Inc. | 10,445 | 27.47 USD | |
| 17 Jun 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 27,881 | 0.00 USD | deriv |
| 07 Mar 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 47,500 | 0.00 USD | deriv |
| 07 Mar 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 32,079 | 0.00 USD | deriv |
| 24 Apr 2023 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 111,525 | 0.00 USD | deriv |